Loading…
← CockpitCompetitor Analysis › BALAMINES.NS Balaji Amines LimitedOpen in the cockpit ↗

Balaji Amines LimitedBALAMINES.NSCompetitor analysis, valuation and peers

India · INR·Chemicals›Chemicals: Specialty
Momentum neutral 48
Mkt cap
$658M
US dollars, full cap
Free float
32%
of shares outstanding
$/day
$3.53M
20-day average traded
Fwd P/E
34.2×
forward earnings
ROIC−WACC
-8.9 pp
WACC 18.7%
Hurdle
n/a
no reverse DCF
Next earnings
77 days
3 Feb 2027
Close · INR₹1,898
1D-1.7%
1W+4.1%
1M-4.7%
3M-9.8%
6M+11.1%
YTD+69.3%
1Y+49.5%
ATR %4.3%
Beta1.30
52w lowhigh27.8% off high

What Balaji Amines does

Employees: 1,266

Balaji Amines at a glance

Size Balaji Amines (BALAMINES.NS) is an India Materials company (Chemicals: Specialty) with a market value of $658M, the 752nd largest of 1,066 India companies the cockpit tracks. Shares closed at ₹1,898 on 18 Nov 2026.

Performance Over six months the shares gained 11.1%, against -34.2% for the median peer and +3.8% for the India market (cap-weighted) — 2nd highest of 21 in its peer set.

Growth Revenue grew 20.9% over the last twelve months (peer median +10.3%); the operating margin is 18.9% (peer median 6.7%).

Valuation It trades at 34.2× forward earnings against a peer median of 23.0× (5th most expensive of 12).

Capital Return on invested capital runs 8.9 points below its cost of capital (18.7% WACC).

Next results Next results expected around 3 Feb 2027 (exchange calendar; dates can move).

Relative performance

7510012521 May 202621 Aug 202618 Nov 2026BALAMINES.NS 104Peer median 69
Six months, rebased to 100: Balaji Amines against the median of its 20 peers (local-currency closes).

Balaji Amines financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹16.5B₹14.1B₹13.9B₹16.1B₹23.4B
Revenue growth—+1%-14%-31%—
Gross profit₹5.74B₹2.71B₹2.75B₹3.50B₹6.55B
EBITDA₹3.68B₹2.54B₹2.36B₹3.07B₹6.05B
Net income₹2.37B₹1.67B₹1.58B₹2.05B₹3.26B
Free cash flown/a-₹3.44B₹875M₹966M₹2.54B
Capital expendituren/a₹5.40B₹1.87B₹2.55B₹1.20B
Total debt₹1.61B₹1.33B₹110M₹197M₹576M

Quarterly statements and history in the cockpit →

Balaji Amines competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%-20%-10%0%3013496032178014000210301419300727300586WAGA688219301076DQ600230300758402837884770EXPL002165688733093370BALAMINES.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Balaji Amines is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%20×40×30134960321730072730107660023030075840284770EXPL688733093370BALAMINES.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Balaji Amines is the large dot.

Balaji Amines competitors and peer comparison

How Balaji Amines compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Balaji Amines against its 20 peers (data as of 18 Nov 2026)
MeasureBALAMINES.NSPeer medianRank in peer set
1-month return-4.7%-9.5%7th highest of 21
6-month return+11.1%-34.2%2nd highest of 21
Distance from 52-week high-27.8%-49.0%5th highest of 21
Revenue growth (TTM)+20.9%+10.3%4th highest of 21
Operating margin18.9%6.7%2nd highest of 21
Forward P/E34.2×23.0×5th most expensive of 12
ROIC minus cost of capital-8.9 pp-1.8 pp4th lowest of 20
EV / EBITDA17.0×10.1×2nd most expensive of 8
Net debt / EBITDA-0.2×1.2×4th least indebted of 8

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Balaji Amines BALAMINES.NSIndia$658M+11%+21%19%34.2×n/an/a
Liaoning Xinde New Material Technology 301349.SZChina$660M-34%+63%7%26.4×n/an/a
Yuanli Chemical 603217.SSChina$657M-34%+19%9%17.8×n/an/a
Chori 8014.TJapan$657M0%+3%4%n/a-11.9%+6.7%
DL 000210.KSSouth Korea$666M-36%+5%10%n/a-7.5%+27.7%
Shanghai Allied Industrial 301419.SZChina$666M-4%+19%14%n/an/an/a
Ningbo Runhe High-Tech Materials 300727.SZChina$648M-38%+18%5%39.7×32.2%+14.6%
Malion New Materials 300586.SZChina$675M-45%+4%-4%n/an/an/a
Waga Energy WAGA.PAFrance$642M-3%+7%-20%n/an/an/a
Orinko Advanced Plastics 688219.SSChina$677M-31%+13%2%n/a13.8%+9.5%
Sino-High (China) 301076.SZChina$640M-43%+10%13%49.6×34.0%+9.1%
Daqo New Energy Corp Sponsored ADR DQUnited States$639M-46%-21%-70%n/an/an/a
Hebei Cangzhou Dahua 600230.SSChina$687M-35%-1%4%15.4×-1.5%+22.6%
Anshan Hifichem 300758.SZChina$631M-26%+11%9%46.4×16.0%+8.2%
Ishihara Sangyo Kaisha 4028.TJapan$631M-7%+3%10%11.6×2.1%+8.8%
Hanking Gold International 3788.HKHong Kong$690M-26%-19%8%n/an/an/a
Allied Supreme 4770.TWTaiwan$628M+22%-5%21%13.0×1.3%+12.4%
Societe Explosifs et Produits Chimiques EXPL.PAFrance$694M+8%+13%7%19.5×8.5%+9.8%
Hongbaoli 002165.SZChina$695M-41%+10%-19%n/an/an/a
Anhui Estone Materials Technology 688733.SSChina$622M-43%+52%-2%47.7×n/an/a
Foosung 093370.KSSouth Korea$697M-34%+41%11%23.0×n/an/a

Questions

Which companies are Balaji Amines's closest peers?
The cockpit's peer set: Liaoning Xinde New Material Technology (301349.SZ), Yuanli Chemical (603217.SS), Chori (8014.T), DL (000210.KS), Shanghai Allied Industrial (301419.SZ), Ningbo Runhe High-Tech Materials (300727.SZ), Malion New Materials (300586.SZ), Waga Energy (WAGA.PA).
Is Balaji Amines expensive compared with its peers?
On forward p/e it trades at 34.2× against a peer median of 23.0×, 5th most expensive of 12 in its peer set.
How has Balaji Amines stock performed?
Over six months to 18 Nov 2026 the shares returned +11.1% against -34.2% for the median peer; over one year +49.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.